Premium
Choosing the right TKI for chronic myeloid leukemia: When the truth lies in “long‐term” safety and efficacy
Author(s) -
GambacortiPasserini Carlo,
Piazza Rocco
Publication year - 2011
Publication title -
american journal of hematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.456
H-Index - 105
eISSN - 1096-8652
pISSN - 0361-8609
DOI - 10.1002/ajh.22084
Subject(s) - nilotinib , medicine , imatinib , myeloid leukemia , imatinib mesylate , oncology , surgery
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom